[
  {
    "key": "ap1_4",
    "wrappers": [
      "expansion-panel"
    ],
    "templateOptions": {
      "label": "Specific ethical aspects",
      "expanded": true
    },
    "fieldGroup": [
      {
        "wrappers": [
          "info-div"
        ],
        "template": "<p>The description with regard to specific ethical issues will depend on the committee to which the annual report is addressed and will reflect progress in the reporting year. <ul><li>For the CEI, progress and issues arising with regard to risk/benefit aspects, information and consent, confidentiality, etc.</li><li>For the CEEA, progress and issues arising with regard to replacement, refinement and reduction.</li><li>For CBE, progress and issues arising from the prevention of health or environmental risks related to biological agents or genetically modified organisms under research.</li></ul></p>"
      },
      {
        "template": "Briefly describe how the ethical aspects of the project are progressing and point out any issues encountered and solutions, if any."
      },
      {
        "key": "aspectosEticos",
        "type": "i18n-textarea",
        "templateOptions": {
          "placeholder": "Description",
          "label": "Description",
          "required": false,
          "autosize": true,
          "autosizeMinRows": "1",
          "autosizeMaxRows": "20"
        }
      }
    ]
  }
]